Medicare and Medicaid Programs; Application From The Compliance Team (TCT) for Initial CMS Approval of its Diabetes Outpatient Self-Management Training Accreditation Program, 49739-49741 [2019-20466]
Download as PDF
jbell on DSK3GLQ082PROD with NOTICES
Federal Register / Vol. 84, No. 184 / Monday, September 23, 2019 / Notices
approved collection; Title of
Information Collection: Medicaid
Program Face-to-Face Requirements for
Home Health Services and Supporting
Regulations; Use: 42 CFR 440.70(f) and
(g) requires that physicians (or for
medical equipment, authorized nonphysician practitioners (NPPs)
including nurse practitioners, clinical
nurse specialists and physician
assistants) document that there was a
face-to-face encounter with the
Medicaid beneficiary prior to the
physician making a certification that
home health services are required. The
burden associated with this requirement
is the time and effort to complete this
documentation. The burden also
includes writing, typing, or dictating the
face-to-face documentation and signing/
dating the documentation. Form
Number: CMS–10609 (OMB control
number: 0938–1319); Frequency:
Occasionally; Affected Public: Private
sector (business or other for-profits);
Number of Respondents: 381,148; Total
Annual Responses: 1,143,443; Total
Annual Hours: 190,955. (For policy
questions regarding this collection
contact Alexandra Smilow at 410–786–
0790.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Bid Pricing Tool
(BPT) for Medicare Advantage (MA)
Plans and Prescription Drug Plans
(PDP); Use: Under the Medicare
Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA), and
implementing regulations at 42 CFR,
Medicare Advantage organizations
(MAO) and Prescription Drug Plans
(PDP) are required to submit an
actuarial pricing ‘‘bid’’ for each plan
offered to Medicare beneficiaries for
approval by the Centers for Medicare &
Medicaid Services (CMS).
Medicare Advantage organizations
(MAO) and Prescription Drug Plans
(PDP) are required to submit an
actuarial pricing ‘‘bid’’ for each plan
offered to Medicare beneficiaries for
approval by CMS. The MAOs and PDPs
use the Bid Pricing Tool (BPT) software
to develop their actuarial pricing bid.
The competitive bidding process
defined by the ‘‘The Medicare
Prescription Drug, Improvement, and
Modernization Act’’ (MMA) applies to
both the MA and Part D programs. It is
an annual process that encompasses the
release of the MA rate book in April, the
bid’s that plans submit to CMS in June,
and the release of the Part D and RPPO
benchmarks, which typically occurs in
August. Form Number: CMS–10142
(OMB control number: 0938–0944);
Frequency: Yearly; Affected Public:
VerDate Sep<11>2014
17:55 Sep 20, 2019
Jkt 247001
Private sector (business or other forprofits); Number of Respondents: 555;
Total Annual Responses: 4,995; Total
Annual Hours: 149,850. (For policy
questions regarding this collection
contact Rachel Shevland at 410–786–
3026.)
Dated: September 18, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2019–20484 Filed 9–20–19; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3387–PN]
Medicare and Medicaid Programs;
Application From The Compliance
Team (TCT) for Initial CMS Approval of
its Diabetes Outpatient SelfManagement Training Accreditation
Program
Centers for Medicare and
Medicaid Services, HHS.
ACTION: Notice with request for
comment.
AGENCY:
This proposed notice
acknowledges the receipt of an
application from The Compliance Team
for initial recognition as a national
accrediting organization for accrediting
entities that wish to furnish diabetes
outpatient self-management training
services to Medicare beneficiaries.
DATES: To be assured consideration,
comments must be received at one of
the addresses provided below, no later
than 5 p.m. on October 23, 2019.
ADDRESSES: In commenting, please refer
to file code CMS–3387–PN. Because of
staff and resource limitations, we cannot
accept comments by facsimile (FAX)
transmission.
Comments, including mass comment
submissions, must be submitted in one
of the following three ways (please
choose only one of the ways listed):
1. Electronically. You may submit
electronic comments on this regulation
to https://www.regulations.gov. Follow
the ‘‘Submit a comment’’ instructions.
2. By regular mail. You may mail
written comments to the following
address ONLY:
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Attention: CMS–3387–
PN, P.O. Box 8010, Baltimore, MD
21244–8010.
SUMMARY:
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
49739
Please allow sufficient time for mailed
comments to be received before the
close of the comment period.
3. By express or overnight mail. You
may send written comments to the
following address ONLY:
Centers for Medicare & Medicaid
Services, Department of Health and
Human Services, Attention: CMS–3387–
PN, Mail Stop C4–26–05, 7500 Security
Boulevard, Baltimore, MD 21244–1850.
For information on viewing public
comments, see the beginning of the
SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT:
Christina Mister-Ward, (410) 786–2441.
Shannon Freeland, (410) 786–4348.
Lillian Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All
comments received before the close of
the comment period are available for
viewing by the public, including any
personally identifiable or confidential
business information that is included in
a comment. We post all comments
received before the close of the
comment period on the following
website as soon as possible after they
have been received: https://
www.regulations.gov . Follow the search
instructions on that website to view
public comments.
I. Background
Diabetes outpatient self-management
training services is defined at section
1861(qq)(1) of the Social Security Act
(the Act) as ‘‘educational and training
services furnished (at such times as the
Secretary determines appropriate) to an
individual with diabetes by a certified
provider (as described in paragraph
(2)(A)) in an outpatient setting by an
individual or entity who meets the
quality standards described in
paragraph (2)(B), but only if the
physician who is managing the
individual’s diabetic condition certifies
that such services are needed under a
comprehensive plan of care related to
the individual’s diabetic condition to
ensure therapy compliance or to provide
the individual with necessary skills and
knowledge (including skills related to
the self-administration of injectable
drugs) to participate in the management
of the individual’s condition.’’
In addition, section 1861(qq)(2)(A) of
the Act describes a ‘‘certified provider’’
as a physician, or other individual or
entity designated by the Secretary of the
Department of Health and Human
Services (the Secretary), that, in
addition to providing diabetes
outpatient self-management training
services, provides other items or
services for which payment may be
E:\FR\FM\23SEN1.SGM
23SEN1
jbell on DSK3GLQ082PROD with NOTICES
49740
Federal Register / Vol. 84, No. 184 / Monday, September 23, 2019 / Notices
made under this title. Section
1861(qq)(2)(B) of the Act further
specifies that a physician, or such other
individual or entity, must meet the
quality standards established by the
Secretary, except that the physician or
other individual or entity shall be
deemed to have met such standards if
the physician or other individual or
entity meets applicable standards
originally established by the National
Diabetes Advisory Board and
subsequently revised by organizations
who participated in the establishment of
standards by such Board, or is
recognized by an organization that
represents individuals (including
individuals under this title) with
diabetes as meeting standards for
furnishing the services.
The statute also permits diabetes
outpatient self-management training
service programs to be deemed to have
met Medicare regulatory quality
standards if they are accredited by an
organization approved by the Centers
for Medicare & Medicaid Services
(CMS). A national accrediting
organization (AO) must have an
agreement in effect with the Secretary
and meet the standards and
requirements specified in 42 CFR part
410, subpart H, to qualify for deeming
authority. Our regulations pertaining to
the application procedures to be an
approved national accreditation
organization for diabetes outpatient selfmanagement training are specified at
§ 410.142 (CMS process for approving
national accreditation organizations). A
national accreditation organization
applying for deeming authority must
provide us with reasonable assurance
that the AO requires accredited entities
to meet CMS’ quality standards, the
National Standards for Diabetes SelfManagement Education and Support
standards, or alternative requirements
that meet or exceed our requirements
that have been developed by a national
accreditation organization and approved
by CMS. (See § 410.144 Quality
standards for deemed entities.) We may
approve and recognize a nonprofit
organization with demonstrated
experience in representing the interests
of individuals with diabetes to accredit
entities to furnish training. The national
accreditation organization, after being
approved and recognized by CMS, may
accredit an entity to meet one of the sets
of quality standards in § 410.144
(Quality standards for deemed entities).
II. Approval of Accreditation
Organizations
Section 1865(a)(2) of the Act and
§ 410.142 require that our findings
concerning review and approval of a
VerDate Sep<11>2014
17:55 Sep 20, 2019
Jkt 247001
national AO’s requirements consider,
among other factors, the applying AO’s
requirements for accreditation; survey
procedures; resources for conducting
required surveys; capacity to furnish
information for use in enforcement
activities; monitoring procedures for
provider entities found not in
compliance with the conditions or
requirements; and ability to provide
CMS with the necessary data for
validation.
Section 1865(a)(3) of the Act and
§ 410.142(d) require that we publish,
within 60 days after receipt of an
organization’s complete application, a
notice identifying the national
accrediting body making the request,
describing the nature of the request, and
providing at least a 30-day public
comment period. Section 1865(a)(3)(A)
of the Act further states, we have 210
days from the receipt of a complete
application to publish notice of
approval or denial of the application.
The purpose of this proposed notice
is to inform the public of The
Compliance Team’s (TCT’s) initial
request for CMS approval of its diabetes
outpatient self-management training
accreditation program. This notice also
solicits public comment on whether
TCT’s requirements meet or exceed the
Medicare conditions for certification for
diabetes outpatient self-management
training services.
III. Evaluation of Deeming Authority
Request
TCT submitted all the necessary
materials to enable us to make a
determination concerning its request for
initial CMS approval of its diabetes
outpatient self-management training
accreditation program. This application
was determined to be complete on July
27, 2019. Under section 1865(a)(2) of the
Act and our regulations at § 410.142, our
review and evaluation of TCT will be
conducted in accordance with our
regulations, including:
• The requirements and quality
standards TCT uses to accredit entities
to furnish training.
• TCT’s accreditation process to
determine the following:
++ Frequency of accreditation.
++ Copies of accreditation forms,
guidelines, and instructions to
evaluators.
++ The accreditation review process
and the accreditation status decision
making process.
++ The procedures used to notify a
deemed entity of deficiencies in its
diabetes outpatient self-management
training program and procedures to
monitor the correction of those
deficiencies.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
++ The procedures used to enforce
compliance with the accreditation
requirements and standards.
++ Detailed information about the
individuals who perform evaluations for
the organization.
++ A description of the organization’s
data management and analysis system
for its accreditation activities and
decisions, including reports, tables, and
other displays generated by that system.
++ A description of the organization’s
procedures for responding to and
investigating complaints against an
approved entity, including policies and
procedures regarding coordination of
these activities with appropriate
licensing bodies, ombudsmen programs,
and CMS.
++ A description of the organization’s
policies and procedures for withholding
or removing a certificate of accreditation
for failure to meet the organization’s
standards or requirements, and other
actions the organization takes in
response to noncompliance with its
standards and requirements.
++ A description of all types (for
example, full or partial) and categories
(for example, provisional, conditional,
or temporary) of accreditation offered by
the organization, the duration of each
type and category of accreditation, and
a statement identifying the types and
categories that will serve as a basis for
accreditation if CMS approves the
organization.
++ A list of all of the approved
entities currently accredited to furnish
training and the type, category, and
expiration date of the accreditation held
by each of them.
++ The name and address of each
person with an ownership or control
interest in the organization.
++ Documentation that demonstrates
its ability to furnish CMS with
electronic data in CMS-compatible
format.
++ A resource analysis that
demonstrates that its staffing, funding,
and other resources are adequate to
perform the required accreditation
activities.
++ A statement acknowledging that,
as a condition for approval and
recognition by CMS of its accreditation
program, it agrees to comply with the
requirements set forth in §§ 410.142
through 410.146.
++ Additional information CMS
requests to enable it to respond to the
organization’s request for CMS approval
and recognition of its accreditation
program to accredit entities to furnish
training.
Upon completion of our evaluation,
including evaluation of comments
received as a result of this notice, we
E:\FR\FM\23SEN1.SGM
23SEN1
Federal Register / Vol. 84, No. 184 / Monday, September 23, 2019 / Notices
will publish a final notice in the Federal
Register announcing the result of our
evaluation.
IV. Collection of Information
Requirements
This document does not impose
information collection and
requirements, that is, reporting,
recordkeeping or third party disclosure
requirements. Consequently, there is no
need for review by the Office of
Management and Budget under the
authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
V. Response to Comments
Because of the large number of public
comments we normally receive on
Federal Register documents, we are not
able to acknowledge or respond to them
individually. We will consider all
comments we receive by the date and
time specified in the DATES section of
this preamble, and, when we proceed
with a subsequent document, we will
respond to the comments in the
preamble to that document.
Dated: September 6, 2019.
Seema Verma,
Administrator, Centers for Medicare &
Medicaid Services.
[FR Doc. 2019–20466 Filed 9–20–19; 8:45 am]
BILLING CODE 4120–01–P
You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Food and Drug Administration
[Docket No. FDA–2019–D–3805]
The Accreditation Scheme for
Conformity Assessment Pilot Program;
Draft Guidance for Industry,
Accreditation Bodies, Testing
Laboratories, and Food and Drug
Administration Staff; Availability
Food and Drug Administration,
HHS.
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of the draft
guidance entitled ‘‘The Accreditation
Scheme for Conformity Assessment
(ASCA) Pilot Program.’’ The Pilot
Accreditation Scheme for Conformity
Assessment Program (hereafter referred
to as the ASCA Pilot) is authorized
under the Federal Food, Drug, and
Cosmetic Act (FD&C Act). In accordance
with amendments made to the FD&C
Act by the FDA Reauthorization Act of
2017 (FDARA) and as part of the
enactment of the Medical Device User
Fee Amendments of 2017 (MDUFA IV),
jbell on DSK3GLQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:55 Sep 20, 2019
Submit either electronic or
written comments on the draft guidance
by December 23, 2019 to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance.
DATES:
ADDRESSES:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
AGENCY:
FDA was directed to issue a draft
guidance regarding the goals and
implementation of the ASCA Pilot. The
establishment of the goals, scope,
procedures, and a suitable framework
for the voluntary ASCA Pilot supports
the Agency’s continued efforts to use its
scientific resources effectively to protect
and promote public health by
simplifying certain aspects of premarket
review, thereby reducing burdens on the
Agency for individual submissions.
FDA believes the voluntary ASCA Pilot
may further encourage international
harmonization of medical device
regulation because it incorporates
elements, where appropriate, from a
well-established set of international
conformity assessment practices and
standards (e.g., ISO/IEC 17000 series).
The voluntary ASCA Pilot does not
supplant or alter any other existing
statutory or regulatory requirements
governing the decision-making process
for premarket submissions. This draft
guidance is not final nor is it in effect
at this time.
Jkt 247001
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
49741
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2019–D–3805 for ‘‘The Accreditation
Scheme for Conformity Assessment
(ASCA) Pilot Program; Draft Guidance
for Industry, Accreditation Bodies,
Testing Laboratories, and Food and
Drug Administration Staff.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://www.gpo.gov/
fdsys/pkg/FR-2015-09-18/pdf/201523389.pdf.
Docket: For access to the docket to
read background documents or the
E:\FR\FM\23SEN1.SGM
23SEN1
Agencies
[Federal Register Volume 84, Number 184 (Monday, September 23, 2019)]
[Notices]
[Pages 49739-49741]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-20466]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3387-PN]
Medicare and Medicaid Programs; Application From The Compliance
Team (TCT) for Initial CMS Approval of its Diabetes Outpatient Self-
Management Training Accreditation Program
AGENCY: Centers for Medicare and Medicaid Services, HHS.
ACTION: Notice with request for comment.
-----------------------------------------------------------------------
SUMMARY: This proposed notice acknowledges the receipt of an
application from The Compliance Team for initial recognition as a
national accrediting organization for accrediting entities that wish to
furnish diabetes outpatient self-management training services to
Medicare beneficiaries.
DATES: To be assured consideration, comments must be received at one of
the addresses provided below, no later than 5 p.m. on October 23, 2019.
ADDRESSES: In commenting, please refer to file code CMS-3387-PN.
Because of staff and resource limitations, we cannot accept comments by
facsimile (FAX) transmission.
Comments, including mass comment submissions, must be submitted in
one of the following three ways (please choose only one of the ways
listed):
1. Electronically. You may submit electronic comments on this
regulation to https://www.regulations.gov. Follow the ``Submit a
comment'' instructions.
2. By regular mail. You may mail written comments to the following
address ONLY:
Centers for Medicare & Medicaid Services, Department of Health and
Human Services, Attention: CMS-3387-PN, P.O. Box 8010, Baltimore, MD
21244-8010.
Please allow sufficient time for mailed comments to be received
before the close of the comment period.
3. By express or overnight mail. You may send written comments to
the following address ONLY:
Centers for Medicare & Medicaid Services, Department of Health and
Human Services, Attention: CMS-3387-PN, Mail Stop C4-26-05, 7500
Security Boulevard, Baltimore, MD 21244-1850.
For information on viewing public comments, see the beginning of
the SUPPLEMENTARY INFORMATION section.
FOR FURTHER INFORMATION CONTACT: Christina Mister-Ward, (410) 786-2441.
Shannon Freeland, (410) 786-4348. Lillian Williams, (410) 786-8636.
SUPPLEMENTARY INFORMATION:
Inspection of Public Comments: All comments received before the
close of the comment period are available for viewing by the public,
including any personally identifiable or confidential business
information that is included in a comment. We post all comments
received before the close of the comment period on the following
website as soon as possible after they have been received: https://www.regulations.gov . Follow the search instructions on that website to
view public comments.
I. Background
Diabetes outpatient self-management training services is defined at
section 1861(qq)(1) of the Social Security Act (the Act) as
``educational and training services furnished (at such times as the
Secretary determines appropriate) to an individual with diabetes by a
certified provider (as described in paragraph (2)(A)) in an outpatient
setting by an individual or entity who meets the quality standards
described in paragraph (2)(B), but only if the physician who is
managing the individual's diabetic condition certifies that such
services are needed under a comprehensive plan of care related to the
individual's diabetic condition to ensure therapy compliance or to
provide the individual with necessary skills and knowledge (including
skills related to the self-administration of injectable drugs) to
participate in the management of the individual's condition.''
In addition, section 1861(qq)(2)(A) of the Act describes a
``certified provider'' as a physician, or other individual or entity
designated by the Secretary of the Department of Health and Human
Services (the Secretary), that, in addition to providing diabetes
outpatient self-management training services, provides other items or
services for which payment may be
[[Page 49740]]
made under this title. Section 1861(qq)(2)(B) of the Act further
specifies that a physician, or such other individual or entity, must
meet the quality standards established by the Secretary, except that
the physician or other individual or entity shall be deemed to have met
such standards if the physician or other individual or entity meets
applicable standards originally established by the National Diabetes
Advisory Board and subsequently revised by organizations who
participated in the establishment of standards by such Board, or is
recognized by an organization that represents individuals (including
individuals under this title) with diabetes as meeting standards for
furnishing the services.
The statute also permits diabetes outpatient self-management
training service programs to be deemed to have met Medicare regulatory
quality standards if they are accredited by an organization approved by
the Centers for Medicare & Medicaid Services (CMS). A national
accrediting organization (AO) must have an agreement in effect with the
Secretary and meet the standards and requirements specified in 42 CFR
part 410, subpart H, to qualify for deeming authority. Our regulations
pertaining to the application procedures to be an approved national
accreditation organization for diabetes outpatient self-management
training are specified at Sec. 410.142 (CMS process for approving
national accreditation organizations). A national accreditation
organization applying for deeming authority must provide us with
reasonable assurance that the AO requires accredited entities to meet
CMS' quality standards, the National Standards for Diabetes Self-
Management Education and Support standards, or alternative requirements
that meet or exceed our requirements that have been developed by a
national accreditation organization and approved by CMS. (See Sec.
410.144 Quality standards for deemed entities.) We may approve and
recognize a nonprofit organization with demonstrated experience in
representing the interests of individuals with diabetes to accredit
entities to furnish training. The national accreditation organization,
after being approved and recognized by CMS, may accredit an entity to
meet one of the sets of quality standards in Sec. 410.144 (Quality
standards for deemed entities).
II. Approval of Accreditation Organizations
Section 1865(a)(2) of the Act and Sec. 410.142 require that our
findings concerning review and approval of a national AO's requirements
consider, among other factors, the applying AO's requirements for
accreditation; survey procedures; resources for conducting required
surveys; capacity to furnish information for use in enforcement
activities; monitoring procedures for provider entities found not in
compliance with the conditions or requirements; and ability to provide
CMS with the necessary data for validation.
Section 1865(a)(3) of the Act and Sec. 410.142(d) require that we
publish, within 60 days after receipt of an organization's complete
application, a notice identifying the national accrediting body making
the request, describing the nature of the request, and providing at
least a 30-day public comment period. Section 1865(a)(3)(A) of the Act
further states, we have 210 days from the receipt of a complete
application to publish notice of approval or denial of the application.
The purpose of this proposed notice is to inform the public of The
Compliance Team's (TCT's) initial request for CMS approval of its
diabetes outpatient self-management training accreditation program.
This notice also solicits public comment on whether TCT's requirements
meet or exceed the Medicare conditions for certification for diabetes
outpatient self-management training services.
III. Evaluation of Deeming Authority Request
TCT submitted all the necessary materials to enable us to make a
determination concerning its request for initial CMS approval of its
diabetes outpatient self-management training accreditation program.
This application was determined to be complete on July 27, 2019. Under
section 1865(a)(2) of the Act and our regulations at Sec. 410.142, our
review and evaluation of TCT will be conducted in accordance with our
regulations, including:
The requirements and quality standards TCT uses to
accredit entities to furnish training.
TCT's accreditation process to determine the following:
++ Frequency of accreditation.
++ Copies of accreditation forms, guidelines, and instructions to
evaluators.
++ The accreditation review process and the accreditation status
decision making process.
++ The procedures used to notify a deemed entity of deficiencies in
its diabetes outpatient self-management training program and procedures
to monitor the correction of those deficiencies.
++ The procedures used to enforce compliance with the accreditation
requirements and standards.
++ Detailed information about the individuals who perform
evaluations for the organization.
++ A description of the organization's data management and analysis
system for its accreditation activities and decisions, including
reports, tables, and other displays generated by that system.
++ A description of the organization's procedures for responding to
and investigating complaints against an approved entity, including
policies and procedures regarding coordination of these activities with
appropriate licensing bodies, ombudsmen programs, and CMS.
++ A description of the organization's policies and procedures for
withholding or removing a certificate of accreditation for failure to
meet the organization's standards or requirements, and other actions
the organization takes in response to noncompliance with its standards
and requirements.
++ A description of all types (for example, full or partial) and
categories (for example, provisional, conditional, or temporary) of
accreditation offered by the organization, the duration of each type
and category of accreditation, and a statement identifying the types
and categories that will serve as a basis for accreditation if CMS
approves the organization.
++ A list of all of the approved entities currently accredited to
furnish training and the type, category, and expiration date of the
accreditation held by each of them.
++ The name and address of each person with an ownership or control
interest in the organization.
++ Documentation that demonstrates its ability to furnish CMS with
electronic data in CMS-compatible format.
++ A resource analysis that demonstrates that its staffing,
funding, and other resources are adequate to perform the required
accreditation activities.
++ A statement acknowledging that, as a condition for approval and
recognition by CMS of its accreditation program, it agrees to comply
with the requirements set forth in Sec. Sec. 410.142 through 410.146.
++ Additional information CMS requests to enable it to respond to
the organization's request for CMS approval and recognition of its
accreditation program to accredit entities to furnish training.
Upon completion of our evaluation, including evaluation of comments
received as a result of this notice, we
[[Page 49741]]
will publish a final notice in the Federal Register announcing the
result of our evaluation.
IV. Collection of Information Requirements
This document does not impose information collection and
requirements, that is, reporting, recordkeeping or third party
disclosure requirements. Consequently, there is no need for review by
the Office of Management and Budget under the authority of the
Paperwork Reduction Act of 1995 (44 U.S.C. 3501 et seq.).
V. Response to Comments
Because of the large number of public comments we normally receive
on Federal Register documents, we are not able to acknowledge or
respond to them individually. We will consider all comments we receive
by the date and time specified in the DATES section of this preamble,
and, when we proceed with a subsequent document, we will respond to the
comments in the preamble to that document.
Dated: September 6, 2019.
Seema Verma,
Administrator, Centers for Medicare & Medicaid Services.
[FR Doc. 2019-20466 Filed 9-20-19; 8:45 am]
BILLING CODE 4120-01-P